NewAmsterdam Pharma Company N.V. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 02/18/2025 | 15.92 M | $409.05 M | 23.81% | 16.80% |
| BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC | 02/14/2025 | 10.72 M | $275.48 M | 2.34% | 11.31% |
| FCPM III SERVICES B.V. | 02/14/2025 | 10.60 M | $272.35 M | -10.43% | 11.18% |
| RA CAPITAL MANAGEMENT, L.P. | 02/14/2025 | 8.85 M | $227.32 M | 9.69% | 9.33% |
| VIKING GLOBAL INVESTORS LP | 02/14/2025 | 6.98 M | $179.35 M | -13.04% | 7.36% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 02/14/2025 | 4.31 M | $110.88 M | 378.44% | 4.55% |
| JENNISON ASSOCIATES LLC | 01/24/2025 | 4.00 M | $102.76 M | 291.91% | 4.22% |
| CORMORANT ASSET MANAGEMENT, LP | 02/14/2025 | 3.25 M | $83.53 M | 31.58% | 3.43% |
| MEDICXI VENTURES MANAGEMENT (JERSEY) LTD | 01/23/2025 | 2.87 M | $73.75 M | 0.00% | 3.03% |
| WOODLINE PARTNERS LP | 02/14/2025 | 2.43 M | $62.47 M | 108.71% | 2.57% |
| SIREN, L.L.C. | 02/14/2025 | 2.10 M | $53.86 M | 127.65% | 2.21% |
| CAPITAL INTERNATIONAL INVESTORS | 02/13/2025 | 2.06 M | $53.01 M | 100.00% | 2.18% |
| POLAR CAPITAL HOLDINGS PLC | 02/14/2025 | 1.75 M | $44.98 M | 16.28% | 1.85% |
| PICTET ASSET MANAGEMENT HOLDING SA | 02/12/2025 | 1.16 M | $29.75 M | 13.83% | 1.22% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 02/14/2025 | 1.05 M | $26.99 M | -23.91% | 1.11% |
| CAPITAL WORLD INVESTORS | 02/13/2025 | 1.02 M | $26.11 M | 100.00% | 1.07% |
| TIMESSQUARE CAPITAL MANAGEMENT, LLC | 02/03/2025 | 895,574 | $23.02 M | 250.87% | 0.95% |
| DECHENG CAPITAL LLC | 02/14/2025 | 770,000 | $19.79 M | 30.51% | 0.81% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 02/14/2025 | 767,522 | $19.73 M | 117.23% | 0.81% |
| BLACKROCK FUNDING, INC. /DE | 02/07/2025 | 441,518 | $11.35 M | 562.21% | 0.47% |
| AFFINITY ASSET ADVISORS, LLC | 02/13/2025 | 425,000 | $10.92 M | -10.03% | 0.45% |
| AVIDITY PARTNERS MANAGEMENT LP | 02/14/2025 | 354,000 | $9.10 M | -60.21% | 0.37% |
| MAVERICK CAPITAL LTD | 02/14/2025 | 350,005 | $9.00 M | 100.00% | 0.37% |
| AMERICAN CENTURY COMPANIES INC | 02/11/2025 | 346,572 | $8.91 M | 100.00% | 0.37% |
| ARROWMARK COLORADO HOLDINGS LLC | 02/14/2025 | 345,048 | $8.87 M | -2.80% | 0.36% |
| CUTTER CAPITAL MANAGEMENT, LP | 02/14/2025 | 337,152 | $8.66 M | 100.00% | 0.36% |
| OPALEYE MANAGEMENT INC. | 02/14/2025 | 325,000 | $8.35 M | -2.99% | 0.34% |
| SLATE PATH CAPITAL LP | 02/14/2025 | 319,000 | $8.20 M | 100.00% | 0.34% |
| MARSHALL WACE, LLP | 02/13/2025 | 288,446 | $7.41 M | 161.93% | 0.30% |
| DUQUESNE FAMILY OFFICE LLC | 02/14/2025 | 287,535 | $7.39 M | 0.00% | 0.30% |
| GMT CAPITAL CORP | 02/14/2025 | 285,136 | $7.33 M | -65.61% | 0.30% |
| EVERSEPT PARTNERS, LP | 02/14/2025 | 275,362 | $7.08 M | -10.41% | 0.29% |
| READYSTATE ASSET MANAGEMENT LP | 02/14/2025 | 260,400 | $6.69 M | 115.21% | 0.27% |
| CENTERBOOK PARTNERS LP | 02/13/2025 | 208,589 | $5.36 M | 143.41% | 0.22% |
| CAPTION MANAGEMENT, LLC | 02/14/2025 | 199,900 | $5.14 M | 100.00% | 0.21% |
| HANDELSBANKEN FONDER AB | 02/03/2025 | 187,404 | $4.82 M | 100.00% | 0.20% |
| ABRDN PLC | 01/24/2025 | 179,060 | $4.60 M | 38.74% | 0.19% |
| MAVEN SECURITIES LTD | 02/14/2025 | 150,000 | $3.86 M | 100.00% | 0.16% |
| OVATA CAPITAL MANAGEMENT LTD | 02/13/2025 | 150,000 | $3.86 M | 100.00% | 0.16% |
| CAPTION MANAGEMENT, LLC | 02/14/2025 | 144,578 | $3.72 M | 100.00% | 0.15% |
| HEALTHINVEST PARTNERS AB | 02/04/2025 | 138,983 | $3.56 M | 0.00% | 0.15% |
| ALYESKA INVESTMENT GROUP, L.P. | 02/14/2025 | 114,707 | $2.95 M | -62.78% | 0.12% |
| SATURN V CAPITAL MANAGEMENT LLC | 02/14/2025 | 100,000 | $2.57 M | 100.00% | 0.11% |
| DCF ADVISERS, LLC | 02/11/2025 | 89,400 | $2.30 M | 162.94% | 0.09% |
| FRED ALGER MANAGEMENT, LLC | 02/14/2025 | 80,579 | $2.07 M | 100.00% | 0.09% |
| MOODY ALDRICH PARTNERS LLC | 01/23/2025 | 79,145 | $2.03 M | -63.44% | 0.08% |
| PARKMAN HEALTHCARE PARTNERS LLC | 02/14/2025 | 76,116 | $1.96 M | -27.74% | 0.08% |
| ALPS ADVISORS INC | 02/13/2025 | 74,709 | $1.92 M | 7.25% | 0.08% |
| STATE STREET CORP | 02/14/2025 | 60,258 | $1.55 M | 58.93% | 0.06% |
| BOOTHBAY FUND MANAGEMENT, LLC | 02/14/2025 | 57,600 | $1.48 M | 100.00% | 0.06% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
NewAmsterdam Pharma Company N.V. institutional Ownership - FAQ's
During the previous two years, 98 institutional investors and hedge funds held shares of NewAmsterdam Pharma Company N.V.. The most heavily invested institutionals were:
Frazier Life Sciences Management, L.P.: 15.92 M
Bain Capital Life Sciences Investors, LLC: 10.72 M
FCPM III SERVICES B.V.: 10.6 M
RA CAPITAL MANAGEMENT, L.P.: 8.85 M
VIKING GLOBAL INVESTORS LP: 6.98 M
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C): 4.31 M
104.07% of NewAmsterdam Pharma Company N.V. stock is owned by institutional investors.
Institutional investors have bought a total of 88.67 M shares in the last 24 months. This purchase volume represents approximately $2.29 B in transactions.